Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Curr Allergy Asthma Rep. 2013 Oct;13(5):462–468. doi: 10.1007/s11882-013-0363-y

Figure 1.

Figure 1

Personalized medicine for innate endotypes in asthma. A schematic view of a sampling strategy, inflammatory measurement, and potential targets for developing actionable individual interventions in asthma. CDKi cyclin-dependent kinase inhibitor, ICS inhaled corticosteroids, SID stable-isotope dilution, SRM-MS selective reaction monitoring mass spectrometry